Commercial lipofection reduced ErbB2 similarly in both tumor lines, whereas HSi reduced ErbB2 only in the HER3+ cells (Figure 7G), demonstrating the specificity of HSi-mediated delivery. This evidence concerns the gene ERBB3 and neoplasm.